DUBLIN, May 26, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/p4x594/specialty_enzymes) has announced the addition of the "Global Specialty Enzymes (Carbohydrases, Protease, Lipase, Polymerases & Nucleases) Market - Trends & Forecasts to 2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
The global specialty enzymes market is growing due to their specific catalytic reaction and yield optimization properties. Diagnostic solutions are experiencing a void between demand and supply due to the increasing health awareness among the global population related to diagnostic tests for various diseases in order to undertake prompt action before it transforms into chronic health conditions.
Due to these reasons, specialty enzymes that are required to manufacture pharmaceutical and diagnostic solutions are experiencing a hike in their demand. Due to intensive research and development efforts conducted for various medical as well as specialty purposes, the market for specialty enzyme is growing in leaps and bounds. The global demand for pharmaceuticals and preventative medication is creating new benchmarks due to an onset of various chronic diseases such as cancer, diabetes, cardiac disorders, etc.
North America is the largest market for the demand of specialty enzyme with the U.S commanding a major share of the market. Growing concerns on health care and cosmetics lead to the demand of pharmaceuticals in drugs and cosmetics. North America is the one of the largest segments for the use of pharmaceutical enzymes.
The demand for specialty enzymes increased in recent years due to the introduction of new drugs that are used in the enzyme replacement therapy. Pharmaceuticals led the global specialty enzymes market in 2012 with around half market share research & development, and diagnostics accounted for second and third of the market leaders in terms of market share respectively.
This research report provides a comprehensive analysis of the global market, which is witnessing a faster growth on account of its diverse applications in the pharmaceuticals, diagnostics, bio-catalysts, and research & biotechnology sectors. Increasing health concerns combined with massive investments in research and development for new product development drives the demand for specialty enzymes, tremendously.
This report also describes the key players in the specialty enzyme business, globally. The regions covered include North America (U.S., Canada, and Mexico), Europe (U.K., Germany, France, Italy, and Spain), Asia-Pacific, and Rest of the World (South Africa and Brazil). The growth strategies of market players have been identified and analyzed. The manufacturers are exploring the Asia-pacific and Latin American markets for potential customers. Novozymes (Denmark), Amano Enzymes Inc. (Japan), Codexis Inc. (U.S.), Sanofi S.A. (France), F.Hoffmann-La Roche Ltd. (Switzerland), etc., are key players in the specialty enzyme industry.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Global Specialty Enzymes Market, By Source
6 Specialty Enzyme Market, By Type
7 Specialty Enzyme Market, By Application
8 Specialty Enzymes Market, By Geography
9 Competitive Landscape
10 Company Profiles
Companies Mentioned:
- Advanced Enzyme Technology Ltd.
- Affymetrix Inc.
- Amano Enzyme Inc.
- Basf
- Bbi Enzymes Ltd.
- Codexis Inc.
- Life Technologies
- Nagase & Co. Ltd.
- Roche Holding Ag.
- Sanofi S.A.
For more information visit http://www.researchandmarkets.com/research/p4x594/specialty_enzymes
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
